RA Capital Management »

Dianthus Therapeutics shares owned by RA Capital Management

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by RA Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $60M 2.3M 25.88
2024-03-31 $70M 2.3M 30.00

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Vaxcyte SH (PCVX)
Janux Therapeutics SH (JANX)
Legend Biotech Corp- SH (LEGN)
Rhythm Pharmaceuticals SH (RYTM)
Biogen SH (BIIB)
Eliem Therapeutics SH (ELYM)
Rxsight SH (RXST)
Avidity Biosciences SH (RNA)
Dyne Therapeutics SH (DYN)
Geron Corp SH (GERN)
Pepgen SH (PEPG)
Tyra Biosciences SH (TYRA)
Evolent Health Inc - A SH (EVH)
Edgewise Therapeutics SH (EWTX)

View all positions for RA Capital Management

Top funds holding Dianthus Therapeutics

Bain Capital Life Sciences Investors
Avidity Partners Management
Fairmount Funds Management
RA Capital Management
VR Adviser
Octagon Capital Advisors
BlackRock
Vanguard Group
5AM Venture Management
Dr. Jeffrey R. Jay, M.D.
Henderson Group
Vestal Point Capital
Geode Capital Management
State Street Corporation
Braidwell

View all funds holding Dianthus Therapeutics